SCHEMBL5579331

SCHEMBL5579331

O=C(O)c1c(-c2ccccc2)oc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
ALDH1A1 P00352 4/20 0.57
HPGD P15428 3/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
RAB9A P51151 2/20 0.57
MAPT P10636 2/20 0.57
HTT P42858 2/20 0.57
NPC1 O15118 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
MAPK1 P28482 2/20 0.57
HSD17B10 Q99714 2/20 0.57
LMNA P02545 2/20 0.57
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
TP53 P04637 1/20 0.57
ABCB1 P08183 1/20 0.57
CYP3A4 P08684 1/20 0.57
CALM1 P0DP23 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14710910 0.89 ANO1 (0.52) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL14788524 0.89 KDM4E (0.62) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL30142386 0.89 KDM4E (0.62) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6527669 0.88 ALDH1A1 (0.69) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL28923320 0.86 L3MBTL1 (0.51) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL30142351 0.86 L3MBTL1 (0.51) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL28302118 0.86 KDM4E (0.63) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL11732285 0.86 L3MBTL1 (0.55) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL31314572 0.86 RAB9A (0.70) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL7068281 0.86 L3MBTL1 (0.67) KDM4EALDH1A1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11339130-B1 Calpain modulators and therapeutic uses thereof BLADE THERAPEUTICS, INC. (US) 2022-05-24 US disclosed
US-10934261-B2 Calpain modulators and therapeutic uses thereof BLADE THERAPEUTICS, INC. (US) 2021-03-02 US disclosed
US-10894776-B2 2021-01-19 US disclosed
CN-104478837-B A kind of preparation method of 2-arylbenzofuran-3-formic acid compound 中科院广州化学有限公司 2016-06-29 CN disclosed
CN-104478837-A Preparation method of 2-arylbenzofuran-3-formic acid compound CAS GUANGZHOU CHEMISTRY CO LTD 2015-04-01 CN disclosed
US-20070148185-A1 Novel therapeutic target for protozoal diseases VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY 2007-06-28 US disclosed
EP-0147044-B1 BENZOFURANCARBOXAMIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM ADRIA LABORATORIES INC. (US) 1990-04-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934261-B2 Calpain modulators and therapeutic uses thereof CAPNS1, CAPN9, CAPN1 KDM4E 3495/4885ALDH1A1 4193/4885HPGD 2346/4885
US-10894776-B2 CAPNS1, CAPN9, CAPN2 KDM4E 3117/4885ALDH1A1 4421/4885HPGD 2414/4885
US-11339130-B1 Calpain modulators and therapeutic uses thereof CAPNS1, CAPN9, CAPN1 KDM4E 3495/4885ALDH1A1 4193/4885HPGD 2346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.